Pharmacists CARE Initiative

Pharmacists CARE Initiative Launch

The Pharmacists CARE Initiative had a successful launch at Western Pharmacy Exchange in April 2024.  We had an amazing turnout of over 130 pharmacists who received training on medication abortion and pharmacy certification. 

“It opens a lot of doors for our pharmacy to gain REMS certification for dispensing mifepristone”

“The knowledge will help me help and understand patients and provide them with access to services”

If you missed the presentation, our home-study program is coming soon!


About the Pharmacists CARE Initiative

Birth Control Pharmacist in partnership with the California Pharmacists Association (CPhA) and the CPhA Foundation is proud to announce the Pharmacists Comprehensive Abortion and Reproductive Health Empowerment (Pharmacists CARE) Initiative to expand medication abortion and comprehensive reproductive health services in California and beyond. This includes the development of a training program and implementation package for pharmacies to become certified to dispense abortion medications and provide the full range of reproductive health services.

  • Live and home-study Medication Abortion Dispensing Certification and Implementation program
  • Implementation package – View the materials here
    • Pharmacy Certification Checklist
    • Mifepristone Dispensing Checklist
    • Mifepristone Reporting Guide
    • Provider Letter Template
    • Medication Abortion Patient Counseling Checklist
    • Medication Abortion Patient Fact Sheet
    • Medication Abortion Patient Education Card
  • Virtual office hours to provide implementation assistance
  • Select California pharmacies will receive a mini grant to cover time to complete training, obtain certification, and establish services in the pharmacy

Sign up to be notified when mini grant applications become available!


In the Media

$2 Million Contract Awarded to the Pharmacists CARE Initiative to Expand Medication Abortion Services in California

California Announces Historic $20 Million Investment to Advance and Improve Access to Reproductive Health Care